Dirk De Ridder1, Michael Kilgard, Navzer Engineer, Sven Vanneste. 1. *Section of Neurosurgery, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Otago, New Zealand; and †University of Texas at Dallas, Richardson; and ‡MicroTransponder Inc., Austin, Texas, U.S.A.
Abstract
OBJECTIVE: Classical neuromodulation consists of applying electrical or magnetic stimuli to the nervous system to modulate ongoing activity and connectivity. However, recently, an exciting novel neuromodulation technique was developed in which stimulation of the vagal nerve was paired with simultaneous presentation of tones, demonstrating that it reverses a tinnitus percept in noise-exposed rats. STUDY DESIGN: To determine whether this therapy could also be effective in humans, we delivered a similar therapy in a patient with chronic tinnitus unresponsive to previous therapies. In this report, we describe the case of a 59-year-old man who suffered from bilateral tinnitus for 14 years that arose after a cervical fusion operation. Pharmacotherapy, transcranial magnetic stimulation, transcranial direct current stimulation, neurofeedback, and bilateral auditory cortex stimulation via implanted electrodes did not improve the tinnitus. After implanting the vagal nerve stimulator, the patient received daily vagus nerve stimulation tone pairings for 4 weeks in a non-placebo-controlled way. RESULTS: At the end of therapy, the patient experienced a significant reduction in tinnitus symptoms that lasted for 2 months after treatment. Tinnitus Handicap Inventory and Tinnitus Reaction Questionnaire were reduced by 48% and 68%, respectively. Symptoms of depression were also improved by 40%, as quantified by the Beck Depression Inventory. Three months after ending therapy, placebo stimulation was performed consisting of only tone presentation without the simultaneous electrical stimuli. This resulted in further continuation of the gradual relapse to the baseline state, without renewed improvement. CONCLUSION: Our results suggest that vagus nerve stimulation paired with tones could become an effective therapy for the treatment of tinnitus.
OBJECTIVE: Classical neuromodulation consists of applying electrical or magnetic stimuli to the nervous system to modulate ongoing activity and connectivity. However, recently, an exciting novel neuromodulation technique was developed in which stimulation of the vagal nerve was paired with simultaneous presentation of tones, demonstrating that it reverses a tinnitus percept in noise-exposed rats. STUDY DESIGN: To determine whether this therapy could also be effective in humans, we delivered a similar therapy in a patient with chronic tinnitus unresponsive to previous therapies. In this report, we describe the case of a 59-year-old man who suffered from bilateral tinnitus for 14 years that arose after a cervical fusion operation. Pharmacotherapy, transcranial magnetic stimulation, transcranial direct current stimulation, neurofeedback, and bilateral auditory cortex stimulation via implanted electrodes did not improve the tinnitus. After implanting the vagal nerve stimulator, the patient received daily vagus nerve stimulation tone pairings for 4 weeks in a non-placebo-controlled way. RESULTS: At the end of therapy, the patient experienced a significant reduction in tinnitus symptoms that lasted for 2 months after treatment. Tinnitus Handicap Inventory and Tinnitus Reaction Questionnaire were reduced by 48% and 68%, respectively. Symptoms of depression were also improved by 40%, as quantified by the Beck Depression Inventory. Three months after ending therapy, placebo stimulation was performed consisting of only tone presentation without the simultaneous electrical stimuli. This resulted in further continuation of the gradual relapse to the baseline state, without renewed improvement. CONCLUSION: Our results suggest that vagus nerve stimulation paired with tones could become an effective therapy for the treatment of tinnitus.
Authors: David T Pruitt; Ariel N Schmid; Lily J Kim; Caroline M Abe; Jenny L Trieu; Connie Choua; Seth A Hays; Michael P Kilgard; Robert L Rennaker Journal: J Neurotrauma Date: 2015-08-05 Impact factor: 5.269
Authors: Michael S Borland; Crystal T Engineer; William A Vrana; Nicole A Moreno; Navzer D Engineer; Sven Vanneste; Pryanka Sharma; Meghan C Pantalia; Mark C Lane; Robert L Rennaker; Michael P Kilgard Journal: Neuroscience Date: 2017-11-10 Impact factor: 3.590
Authors: M S Borland; W A Vrana; N A Moreno; E A Fogarty; E P Buell; P Sharma; C T Engineer; M P Kilgard Journal: Brain Stimul Date: 2015-09-09 Impact factor: 8.955
Authors: Vishnoukumaar Sivaji; Dane W Grasse; Seth A Hays; Jesse E Bucksot; Rahul Saini; Michael P Kilgard; Robert L Rennaker Journal: J Neurosci Methods Date: 2019-03-05 Impact factor: 2.390
Authors: Crystal T Engineer; Jai A Shetake; Navzer D Engineer; Will A Vrana; Jordan T Wolf; Michael P Kilgard Journal: Brain Stimul Date: 2017-01-11 Impact factor: 8.955
Authors: Seth A Hays; Andrea Ruiz; Thelma Bethea; Navid Khodaparast; Jason B Carmel; Robert L Rennaker; Michael P Kilgard Journal: Neurobiol Aging Date: 2016-04-07 Impact factor: 4.673